Advertisement
Advertisement
RLMD
Relmada Therapeutics, Inc. Common Stock
6.66
USDSponsored
+0.15
+2.30%
Jun 25, 10:49 UTC -4
Open
Relmada Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 699.22M |
| Beta | 0.44 |
| Earnings Per Share (EPS) | -1.45 |
| Price-to-Book (P/B) Ratio | 6.45 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -170.83% |
| Current Ratio | 14.62% |
| Free Cash Flow | -45.79M |
Trending Stocks
Advertisement